62.87% | % of shares held by all insiders |
16.33% | % of shares held by institutions |
43.97% | % of float held by institutions |
499 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Baillie Gifford and Company | 6,744,697 | 30 Mar 2022 | 2.73% | 1,150,375,520 |
Primecap Management Company | 4,242,068 | 30 Mar 2022 | 1.72% | 723,527,118 |
Pendal Group Ltd | 1,957,594 | 30 Mar 2022 | 0.79% | 333,887,232 |
Flossbach von Storch AG | 1,920,089 | 30 Mar 2022 | 0.78% | 327,490,379 |
Capital World Investors | 1,896,398 | 30 Dec 2021 | 0.77% | 488,891,404 |
Blackrock Inc. | 1,610,975 | 30 Mar 2022 | 0.65% | 274,767,896 |
Price (T.Rowe) Associates Inc | 1,537,723 | 30 Dec 2021 | 0.62% | 396,424,989 |
Coatue Management Llc | 1,057,661 | 30 Dec 2021 | 0.43% | 272,665,005 |
Susquehanna International Group, LLP | 1,055,566 | 30 Dec 2021 | 0.43% | 272,124,914 |
Fosun International Ltd | 1,053,640 | 30 Mar 2022 | 0.43% | 179,708,838 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Vanguard Horizon Fund-Capital Opportunity Fund | 2,034,146 | 30 Dec 2021 | 0.82% | 524,402,838 |
Primecap Odyssey Aggressive Growth Fund | 1,518,202 | 30 Jan 2022 | 0.62% | 261,252,200 |
iShares NASDAQ Biotechnology ETF | 1,230,349 | 30 Jan 2022 | 0.50% | 211,718,455 |
Price (T.Rowe) Health Sciences Fund | 1,154,231 | 30 Dec 2021 | 0.47% | 297,560,751 |
Advisers Investment Tr-JOHCM International Select Fd | 1,140,549 | 30 Dec 2021 | 0.46% | 294,033,532 |
Europacific Growth Fund | 952,989 | 30 Dec 2021 | 0.39% | 245,680,564 |
New Perspective Fund Inc | 529,631 | 30 Dec 2021 | 0.21% | 136,538,871 |
First Trust NYSE Arca Biotechnology Index Fund | 331,602 | 27 Feb 2022 | 0.13% | 50,008,897 |
Franklin Custodian Funds-Dynatech Fund | 300,000 | 30 Dec 2021 | 0.12% | 77,340,000 |
Fidelity Select Portfolios - Health Care | 265,000 | 27 Feb 2022 | 0.11% | 39,964,650 |